输尿管支架市场（依产品、材料、应用、最终用户、地区划分）2026 年至 2032 年

2026-2032年输尿管支架市场评估

泌尿系统疾病（尤其是肾结石）的发生率不断上升，以及使用微创技术改善患者康復和舒适度，正在推动输尿管支架市场向前发展。据 Verified Market Research 分析师称，输尿管支架市场规模预计将在 2024 年下降至约 5.4854 亿美元，并在预测期内达到 8.4374 亿美元的估值。

支架材料和设计的技术改进，尤其是灵活和生物相容性的选择，正在推动市场需求。这将有助于市场在 2026 年至 2032 年期间以 6.1% 的复合年增长率成长。

输尿管支架市场定义/概述

输尿管支架是一种细而柔软的管子，插入输尿管可帮助将尿液从肾臟排放膀胱，尤其是在尿液正常流动受阻的情况下。这些支架通常用于治疗肾结石、因肿瘤或狭窄引起的输尿管阻塞以及因肿胀或组织修復引起的术后阻塞。输尿管支架是泌尿系统治疗的重要组成部分，因为它可以保持输尿管通畅，确保最佳肾功能，同时缓解与泌尿道阻塞相关的症状。

哪些因素推动了输尿管支架市场需求的激增？

肾结石发生率的不断上升是输尿管支架市场的主要驱动力。美国美国糖尿病、消化和肾臟疾病研究所 (NIDDK) 估计，美国约有 11% 的男性和 9% 的女性患有肾结石。 NIDDK 也指出，美国肾结石的发生率已从 1970 年代末的 3.8% 上升至 2000 年代末的 8.8%。盛行率的增加使得需要进行更多的输尿管支架手术，进而推动市场扩张。

全球人口老化推动了对输尿管支架的需求，因为老年人更容易出现泌尿器官系统问题。世界卫生组织预测，到2030年，六分之一的人将超过60岁。预计到2050年，这一数字将上升到五分之一。从统计数据来看，人口将从2020年的10亿增加到2030年的14亿，再到2050年的21亿。老年人口更容易罹患需要输尿管支架的疾病，刺激市场扩张。

此外，输尿管支架设计和材料的不断进步正在扩大其应用范围，同时改善患者的治疗效果。例如，美国食品药物管理局（FDA）正在积极核准新的输尿管支架技术。牛顿引流器输尿管导管用于从肾臟排放结石碎片，于 2019 年被 FDA 指定为突破性设备。这些改进扩大了输尿管支架的应用范围，并推动了市场成长。根据FDA设备和放射健康中心（CDRH）的数据，2009年至2019年间，创新设备的核准数量增加了25％，这表明医疗设备，尤其是输尿管支架的创新趋势。

哪些因素阻碍了输尿管支架市场的成长？

药物释放型和生物分解性支架是突破性技术的例子，它们有可能提供更好的治疗效果，但其高昂的成本使患者和医疗保健专业人员无法承受，尤其是在资源贫乏的地区。这种经济负担阻碍了人们采用这些先进的解决方案，导致人们依赖无法提供相同好处的廉价替代方案。

输尿管支架留置后出现问题的风险是另一个挑战。患者可能会出现支架移位、卡住和尿道感染等併发症，需要额外的医疗。这些发现不仅影响患者的治疗结果，而且还增加了医疗支出和资源使用，使得医生不愿意提案将支架置入作为第一线治疗方法。

目录

第一章全球输尿管支架市场介绍

• 市场介绍
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章输尿管支架的全球市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

5. 全球输尿管支架市场（依产品）

• 概述
• 开放式支架
• 双J支架
• 封闭式支架
• 多环支架

6. 全球输尿管支架市场（依材料）

• 概述
• 金属支架
• 聚合物支架

7. 全球输尿管支架市场（依应用）

• 概述
• 肾结石
• 肾臟移植
• 瘤
• 尿失禁
• 其他的

8. 全球输尿管支架市场（依最终用户）

• 概述
• 医院
• 诊所
• 门诊手术中心（ASC）

9. 全球输尿管支架市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第十章全球输尿管支架市场的竞争格局

• 概述
• 各公司市场排名
• 主要发展策略

第十一章 公司简介

• Boston Scientific Corporation
• Coloplast Ltd.
• Allium Medical Solutions Ltd.
• Becton, Dickinson and Company
• Cook Group Incorporated
• Braun Melsungen AG
• R. Bard
• Teleflex Incorporated
• Olympus Corporation
• Biomerics

第十二章 重大进展

• 产品发布/开发
• 合併与收购
• 业务扩展
• 伙伴关係与合作

第十三章 附录

• 相关调查

Ureteral Stents Market Valuation - 2026-2032

The rising frequency of urological disorders, especially kidney stones, and the use of minimally invasive techniques that improve patient recovery and comfort, are driving the Ureteral Stents Market forward. According to the analyst from Verified Market Research, the Ureteral Stents Market is estimated to reach a valuation of USD 843.74 Million over the forecast subjugating around USD 548.54 Million valued in 2024.

Technological improvements in stent materials and designs, particularly flexible and biocompatible choices, are driving up market demand. It enables the market to grow at a CAGR of 6.1% from 2026 to 2032.

Ureteral Stents Market: Definition/ Overview

A ureteral stent is a thin, flexible tube put into the ureter to aid in the drainage of urine from the kidney to the bladder, especially when normal urine flow is impeded. These stents are widely used to treat kidney stones, ureteral obstructions caused by tumors or strictures, and post-surgical blockages due to swelling or tissue repair. Ureteral stents are an important component in urological therapies because they maintain the ureter open and assist ensure optimal kidney function while also alleviating symptoms associated with urinary obstructions.

What are the Factors that Surge the Demand for the Ureteral Stents Market?

The increased occurrence of kidney stones is a major driver of the Ureteral Stents Market. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) estimates that kidney stones affect approximately 11% of men and 9% of women in the United States. The NIDDK also notes that the incidence of kidney stones in the United States has risen from 3.8% in the late 1970s to 8.8% in the late 2000s. This increasing prevalence needs more ureteral stent surgeries, which drives market expansion.

The global aging population is driving up demand for ureteral stents, as older persons are more prone to urological problems. The World Health Organization (WHO) predicts that by 2030, one in every six persons will be 60 or older. This number is predicted to rise to one in five by 2050. In statistics, this represents a rise from 1 billion in 2020 to 1.4 billion by 2030 and 2.1 billion by 2050. The elderly population is more vulnerable to disorders that necessitate ureteral stents, fueling market expansion.

Furthermore, continuous advancements in ureteral stent design and materials are broadening their uses while improving patient outcomes. For example, the United States Food and Drug Administration (FDA) has been actively approving novel ureteral stent technology. The Newton-Drainer Ureteral Catheter, which is meant to drain stone fragments from the kidney, was designated a Breakthrough Device by the FDA in 2019. Such improvements are expanding the use of ureteral stents and driving market expansion. According to the FDA's Center for Devices and Radiological Health (CDRH), the number of innovative device approvals increased by 25% between 2009 and 2019, demonstrating a trend toward innovation in medical devices, particularly ureteral stents.

What Factors Hinder the Growth of the Ureteral Stents Market?

Drug-eluting and biodegradable stents are examples of breakthroughs that hold out the potential for better outcomes, but their high cost puts patients and healthcare professionals out of reach, especially in areas with few resources. This financial burden discourages the adoption of these sophisticated solutions, resulting in a reliance on less expensive alternatives that do not provide the same benefits.

The risk of problems following the placing of a ureteral stent presents another difficulty. Patients develop complications such as stent migration, encrustation, and urinary tract infections, requiring extra medical treatments. These consequences not only have an impact on patient outcomes but also raise healthcare expenditures and resource use, making doctors hesitant to propose stenting as a first-line treatment option.

Category-Wise Acumens

How Does the Increasing Adoption of Double Pigtail Stents Drive the Market Growth?

According to VMR analysis, the double pigtail stent segment is estimated to hold the largest market share during the forecast period due to its high biocompatibility, which reduces the chance of unpleasant reactions and problems like infection or tissue irritation. This characteristic makes double pigtail stents the favored option among healthcare professionals, resulting in improved patient outcomes and higher satisfaction rates. Their design enables excellent drainage while decreasing the possibility of encrustation, which increases their attractiveness in clinical settings.

Double pigtail stents' flexibility and simplicity of insertion are also significant factors. Their unique form allows for smoother installation using less invasive techniques, making them easier to manage during treatments. This ease of use not only increases procedural efficiency but also reduces patient discomfort, prompting more healthcare practitioners to employ them for a variety of urological procedures.

Furthermore, the increasing prevalence of urological problems, such as kidney stones and urinary tract blockages, is driving demand for double pigtail stents. As these problems become more widespread, particularly in older populations, healthcare providers rely more on these stents to properly address urinary issues. The increasing prevalence of such illnesses confirms the market dominance of double pigtail stents, which are best adapted to resolving these issues.

How Does the High Prevalence of Kidney Stones Propel the Growth of the Ureteral Stents Market?

The kidney stone segment is estimated to dominate the Ureteral Stents Market during the forecast period due to the high occurrence of kidney stones. Kidney stones impact a large proportion of the global population, creating a growing demand for effective treatment alternatives. Ureteral stents are frequently utilized to relieve obstruction produced by these stones, maintaining correct urine flow and minimizing accompanying pain, emphasizing their critical role in addressing this problem.

Technological developments in stent design are also important for segment growth. Drug-eluting and biodegradable stents are examples of innovations that improve kidney stone treatment effectiveness, patient outcomes, and comfort. These developments not only make it easier to pass stones, but they also reduce complications, leading healthcare practitioners to select ureteral stents as the preferred technique for managing kidney stones.

Furthermore, the growing knowledge and accessibility of healthcare services help to drive the growth of the kidney stones segment. As more patients seek medical assistance for urological disorders, understanding of kidney stone management has grown. This trend promotes timely treatments with ureteral stents, consolidating their position as the preferred method for treating kidney stone-related blockages.

Country/Region-wise Acumens

How Does the High Prevalence of Urological Disorders Influence Growth in North America?

According to VMR analyst, North America is estimated to dominate the Ureteral Stents Market during the forecast period. Urological problems are common in North America, especially in the United States, and are frequently treated using ureteral stents. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), around 11% of men and 6% of women in the United States will have kidney stones at some point in their life. Also, the American Urological Association says that benign prostatic hyperplasia (BPH) affects approximately 50% of men aged 51 to 60 and up to 90% of men over the age of 80, with many requiring ureteral stents as part of their treatment.

Furthermore, the expanding geriatric population in North America is a significant driver of the Ureteral Stents Market, as older persons are more prone to urological problems. According to the United States Census Bureau, by 2030, all baby boomers will be above the age of 65, increasing the number of the elderly population to one in every five individuals. Specifically, the number of Americans aged 65 and over is expected to increase from 52 million in 2018 to 95 million by 2060. This demographic trend is projected to boost demand for urological procedures, such as ureteral stents.

What Factors Contribute to the Potential Opportunities in the Asia Pacific Region?

The Asia Pacific region is estimated to exhibit the highest growth within the Ureteral Stents Market during the forecast period. The Asia Pacific region is experiencing considerable growth in the older population, which is particularly vulnerable to urological illnesses that require ureteral stents. According to the United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), the region's elder population (aged 65 and more) is predicted to more than double from 535 million in 2015 to around 1.3 billion by 2050. In countries such as Japan, the proportion of people aged 65 and more is expected to reach 38% by 2050. This demographic trend is expected to increase demand for ureteral stents and other urological treatments.

Furthermore, the Asia Pacific region is experiencing an increase in urological problems, particularly kidney stones. According to research published in the Asian Journal of Urology, the prevalence of kidney stone illness in China has risen from 4% in the 1980s to 6.4% in the 2000s. According to India's Department of Health & Family Welfare's Annual Report 2020-2021, urolithiasis (kidney stones) is growing more common, with a prevalence rate of 12% in the adult population. This increased disease burden is likely to drive up demand for ureteral stents in the region.

Competitive Landscape

The Ureteral Stents Market has a broad set of participants, including both large global organizations and smaller, specialized firms. This fragmentation encourages innovation, as businesses focus more on developing new stent technologies, such as drug-eluting and biodegradable choices, to improve patient outcomes and satisfaction.

Some of the prominent players operating in the Ureteral Stents Market include:

Boston Scientific Corporation, Coloplast Ltd., Allium Medical Solutions Ltd., Becton, Dickinson and Company, Cook Group Incorporated, Braun Melsungen AG, Bard, Teleflex Incorporated, Olympus Corporation, and Biomerics.

Latest Developments

In May 2022, University Hospitals invented a novel stent developed by Ureteral Stent Co. Lee Ponsky, MD, and obtained FDA Clearance. Ureteral stents facilitate urine flow from the kidney to the bladder, preventing kidney damage caused by kidney stones, strictures, or ureter edema.

In April 2022, Boston Scientific received a bronze Edison Award in the Science & Medical category for its Tria Ureteral Stent. This stent is the first to use proprietary surface technology to prevent the accumulation of calcium and magnesium salt deposits in urine.

Ureteral Stents Market, By Category

• Product:
• Open End Stents
• Double J-Stents
• Closed End Stents
• Multiloop Stents
• Material:
• Metallic Stents
• Polymer Stents
• Application:
• Kidney Stones
• Kidney Transplantation
• Tumors
• Urinary Incontinence
• Others
• End-User:
• Hospitals
• Clinics
• Ambulatory Surgical Centers (ASCs)
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL URETERAL STENTS MARKET

• 1.1 Introduction of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL URETERAL STENTS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL URETERAL STENTS MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Open End Stents
• 5.3 Double J-Stents
• 5.4 Closed End Stents
• 5.5 Multiloop Stents

6 GLOBAL URETERAL STENTS MARKET, BY MATERIAL

• 6.1 Overview
• 6.2 Metallic Stents
• 6.3 Polymer Stents

7 GLOBAL URETERAL STENTS MARKET, BY APPLICATION

• 7.1 Overview
• 7.2 Kidney Stones
• 7.3 Kidney Transplantation
• 7.4 Tumors
• 7.5 Urinary Incontinence
• 7.6 Others

8 GLOBAL URETERAL STENTS MARKET, BY END-USER

• 8.1 Overview
• 8.2 Hospitals
• 8.3 Clinics
• 8.4 Ambulatory Surgical Centers (ASCs)

9 GLOBAL URETERAL STENTS MARKET, BY GEOGRAPHY

• 9.1 Overview
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 U.K.
  • 9.3.3 France
  • 9.3.4 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Rest of Asia Pacific
• 9.5 Rest of the World
  • 9.5.1 Latin America
  • 9.5.2 Middle East and Africa

10 GLOBAL URETERAL STENTS MARKET COMPETITIVE LANDSCAPE

• 10.1 Overview
• 10.2 Company Market Ranking
• 10.3 Key Development Strategies

11 COMPANY PROFILES

• 11.1 Boston Scientific Corporation
  • 11.1.1 Overview
  • 11.1.2 Financial Performance
  • 11.1.3 Product Outlook
  • 11.1.4 Key Developments
• 11.2 Coloplast Ltd.
  • 11.2.1 Overview
  • 11.2.2 Financial Performance
  • 11.2.3 Product Outlook
  • 11.2.4 Key Developments
• 11.3 Allium Medical Solutions Ltd.
  • 11.3.1 Overview
  • 11.3.2 Financial Performance
  • 11.3.3 Product Outlook
  • 11.3.4 Key Developments
• 11.4 Becton, Dickinson and Company
  • 11.4.1 Overview
  • 11.4.2 Financial Performance
  • 11.4.3 Product Outlook
  • 11.4.4 Key Developments
• 11.5 Cook Group Incorporated
  • 11.5.1 Overview
  • 11.5.2 Financial Performance
  • 11.5.3 Product Outlook
  • 11.5.4 Key Developments
• 11.6 Braun Melsungen AG
  • 11.6.1 Overview
  • 11.6.2 Financial Performance
  • 11.6.3 Product Outlook
  • 11.6.4 Key Developments
• 11.7 R. Bard
  • 11.7.1 Overview
  • 11.7.2 Financial Performance
  • 11.7.3 Product Outlook
  • 11.7.4 Key Developments
• 11.8 Teleflex Incorporated
  • 11.8.1 Overview
  • 11.8.2 Financial Performance
  • 11.8.3 Product Outlook
  • 11.8.4 Key Developments
• 11.9 Olympus Corporation
  • 11.9.1 Overview
  • 11.9.2 Financial Performance
  • 11.9.3 Product Outlook
  • 11.9.4 Key Developments
• 11.10 Biomerics
  • 11.10.1 Overview
  • 11.10.2 Financial Performance
  • 11.10.3 Product Outlook
  • 11.10.4 Key Developments

12 KEY DEVELOPMENTS

• 12.1 Product Launches/Developments
• 12.2 Mergers and Acquisitions
• 12.3 Business Expansions
• 12.4 Partnerships and Collaborations

13 Appendix

• 13.1 Related Research